A combination of spirulina and palmitoylethanolamide and / or pharmaceutically acceptable salts or derivatives thereof and their formulations, for use in the prevention and / or treatment of tissue hyperactivity conditions

Abstract

The present invention relates to the combination of spirulina and palmitoylethanolamide (pea) and / or pharmaceutically acceptable derivatives or salts, pharmaceutical formulations comprising the combination of spirulina and pea and / or pharmaceutically acceptable derivatives or their salts, an acceptable excipient, and the use of the combination of spirulina and pea and / or pharmaceutically acceptable derivatives or salts thereof, and formulations comprising said combination, for the prevention and / or treatment of tissue hyperactivation states.In the prevention and / or treatment of alterations of cardiac and / or coronary tissue, in the prevention and / or treatment of alterations of vascular tissue, in the prevention and / or treatment of ophthalmic pathologies, preferably in the prevention and / or treatment of pathologies of macular degeneration and glaucoma, the prevention and / or treatment of dyslipidemia, the prevention and / or treatment of alterations of lung tissue, the prevention and / or treatment of alterations of pelvic tissues, the prevention and / or treatment of cellular alterations due to carcinogenesis, / or in the prevention and / or treatment of dermatological alterations.